Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia

Null mutations in the progranulin gene (GRN, PGRN) were recently identified as the causal mechanism underlying frontotemporal dementia (FTD) with ubiquitin‐positive brain pathology linked to chromosome 17 (FTDU‐17). In a Belgian and French FTD series comprising 332 patients, we reported 13 PGRN null...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human mutation 2007-04, Vol.28 (4), p.416-416
Hauptverfasser: van der Zee, Julie, Le Ber, Isabelle, Maurer-Stroh, Sebastian, Engelborghs, Sebastiaan, Gijselinck, Ilse, Camuzat, Agnès, Brouwers, Nathalie, Vandenberghe, Rik, Sleegers, Kristel, Hannequin, Didier, Dermaut, Bart, Schymkowitz, Joost, Campion, Dominique, Santens, Patrick, Martin, Jean-Jacques, Lacomblez, Lucette, De Pooter, Tim, Peeters, Karin, Mattheijssens, Maria, Vercelletto, Martine, Van den Broeck, Marleen, Cruts, Marc, De Deyn, Peter P., Rousseau, Frederic, Brice, Alexis, Van Broeckhoven, Christine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Null mutations in the progranulin gene (GRN, PGRN) were recently identified as the causal mechanism underlying frontotemporal dementia (FTD) with ubiquitin‐positive brain pathology linked to chromosome 17 (FTDU‐17). In a Belgian and French FTD series comprising 332 patients, we reported 13 PGRN null mutations which were mainly nonsense and frameshift mutations resulting in premature stop codons. Here we report in the same patient series three missense mutations of which two (c.743C>T, p.Pro248Leu and c.1294C>T, p.Arg432Cys) were predicted in silico to severely affect protein folding and/or processing leading to PGRN protein haploinsufficiency. In addition, we observed three sequence variations in the 5' regulatory region that might potentially affect PGRN transcription activity. Our findings extend the mutation spectrum in PGRN leading to loss of functional PGRN as the basis for FTD. © 2007 Wiley‐Liss, Inc.
ISSN:1059-7794
1098-1004
DOI:10.1002/humu.9484